NEB’s pharmacologic profile, which consists of high 1 selectivity and nitric oxide-dependent vasodilatory characteristics produced by activation of 3 receptors in the endothelium, may be appropriate for the genesis of hypertension in younger patients. This evidence concerns the gene NEB and hypertensive disorder.